Author:
Steelman L S,Franklin R A,Abrams S L,Chappell W,Kempf C R,Bäsecke J,Stivala F,Donia M,Fagone P,Nicoletti F,Libra M,Ruvolo P,Ruvolo V,Evangelisti C,Martelli A M,McCubrey J A
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference170 articles.
1. McCubrey J, LaHair M, Franklin RA . Reactive oxygen species-induced activation of the MAP kinase signaling pathway. Antioxidants Redox Signal 2006; 8: 1745–1748.
2. Franklin R, Rodriquez-Mora O, La Hair M, McCubrey JA . Activation of the calcium/calmodulin-dependent protein kinases as a consequence of oxidative stress. Antioxidants Redox Signal 2006; 8: 1807–1817.
3. McCubrey JA, Steelman LS, Kempf CR, Chappell WH, Abrams SL, Stivala F et al. Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways. J Cell Physiol 2011; e-pub ahead of print 1 February 2011; doi:10.1002jcp22647.
4. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 2007; 1773: 1263–1284.
5. Steelman LS, Abrams SL, Whelan J, Bertrand FE, Ludwig DE, Basecke J et al. Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and JAK/STAT pathways to leukemia. Leukemia 2008; 22: 686–707.
Cited by
211 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献